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NOTE
Protecting Minors with Substance Use Disorders: A Closer Look at the
Relationship of Confidentiality with Treatment Options
Katherine Slisz*
INTRODUCTION
Cindy, fourteen, sits in the substance use disorder (SUD) treatment
provider’s office after having traveled there from her parents’ middle-class
suburban home. The provider asks Cindy if she would like to sign the information
release form or keep her treatment information confidential. She thinks for a
moment about her parents, whom she believes would be disappointed to learn of her
SUD. She does not want to upset her parents or face their discipline, so she refuses
to sign the paperwork that would allow the release of her information. This
hypothetical situation provides one example of the lack of understanding many
minors possess when it comes to confidentiality concerning SUD treatment.
SUD is classified as a mental health disorder that “occur[s] when the
recurrent use of alcohol and/or substances causes clinically and functionally
significant impairment, such as health problems, disability, and failure to meet
major responsibilities at work, school, or home.”1 An SUD diagnosis is made based
on evidence of impaired control, social impairment, risky use, and pharmacological
criteria.2 In 2014, of United States adolescents ages 12 to 17, an estimated 5%, or
about 1.3 million adolescents, had SUD.3 The 1.3 million adolescents suffering from
this challenging disorder present vulnerabilities that require caution, care, and
concern in treatment.
Adolescents may find a number of treatments for SUD helpful based on the
individual’s situation.4 Some adolescents receive treatments where providers work
directly with the adolescent to help them cope with their environment and other
providers take group therapy approaches, like family-based treatment.5 Treatment
providers work to allow adolescents to better understand their interactions with
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Indiana University Maurer School of Law, J.D. 2020; Executive Editor, Indiana Journal of Law
& Social Equality, Volume 8.
Mental Health and Substance Use Disorder, SUBSTANCE ABUSE & MENTAL HEALTH SERVS.
ADMIN., https://www.samhsa.gov/disorders/substance-use (last updated Apr. 13, 2019).
AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS (5th ed.
2013).
Age- and Gender-Based Populations, SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN. (Jan.
17, 2018), https://www.samhsa.gov/specific-populations/age-gender-based
[https://web.archive.org/web/20190306023430/https://www.samhsa.gov/specific-populations/agegender-based].
NAT’L INST. ON DRUG ABUSE, PRINCIPLES OF ADOLESCENT SUBSTANCE USE DISORDER TREATMENT
23 (2014).
Id. at 23–25.
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their external environment and how they cope with their desire for substances in
the future.6 Treatment providers also strive to build a system of social support
around adolescents with SUD.7
Confidentiality requirements for substance use treatment were codified in
1975 in 42 CFR Part 2 (Part 2) as part of the Drug Abuse Office and Treatment
Act.8 Within Part 2 of the regulation, 42 CFR 2.14 (Section 2.14) provides minors
similar consent rights as adults, meaning that minors must give consent for their
information to be released to outside parties.9 Individuals having the capacity to
consent to treatment is always assumed under the regulation.10 The regulation
depends on the assumption that minors are more likely to seek treatment when
their SUD treatment provider can promise confidentiality.11 To achieve Section
2.14’s purpose, treatment providers must consider the harm that maintaining
confidentiality will do to the parent-child relationship and the child themselves.12
An examination of SUD’s psychological effect on adolescents is necessary to
understand how Section 2.14 may work in conjunction with minors’ desire for
confidentiality. While confidentiality mandated under Section 2.14 provides
important benefits for adolescents seeking privacy for SUD treatment, there are
many treatment reasons why providers should be reporting care for serious SUD to
parents absent extraordinary circumstances. Therefore, this Note argues that,
based on Section 2.14(c), providers should have more guidance both to supply
adolescents with adequate information about family-based treatment and to protect
the well-being of vulnerable adolescents by sharing more information with parents
and guardians.
Section I provides background surrounding the regulation Part 2, along with
its purpose. Section II discusses minors’ interactions with the health care system,
how substance use affects minors’ brains, and alternative treatments for SUD.
Section III explores why some minors with SUD lack maturity to make the decision
of whether or not to maintain confidentiality, including the importance of medical
informed consent, both medical and legal capacity, traditional legal standards, and
case law. Section IV then examines how these understandings may conflict with or
change the meaning of Section 2.14(c)’s provisions. Finally, Section V proposes a
solution to Section 2.14(c)’s vagueness: a process for providers and psychologists to
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Id. at 21, 23, 25.
Id. at 17–23.
Part 2—Confidentiality of Alcohol and Drug Abuse Patient Records, 40 Fed. Reg. 27,802 (July 1,
1975) (to be codified at 42 C.F.R. pt. 2). See Drug Abuse Office and Treatment Act of 1972, Pub.
L. No. 92-255, 86 Stat. 65 (1972); Comprehensive Alcohol Use and Alcoholism Prevention,
Treatment, and Rehabilitative Act of 1970, Pub. L. No. 91-616, 84 Stat. 1848 (1970) (providing
legislative authority to enact the 1975 regulation).
See 42 C.F.R. § 2.14(a) ( 2018).
Id.
See infra note 46 and accompanying text.
See Part 2—Confidentiality of Alcohol and Drug Abuse Patient Records, 40 Fed. Reg. 27,802.
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determine if minors with SUD have been fully informed of the importance of social
support and have the maturity to consent to treatment.
I.

BACKGROUND AND PURPOSE OF 42 CFR PART 2

Federal privacy regulations exist in the current healthcare system to protect
individuals from unwanted information sharing.13 Part 2 was created to allow
individuals with SUD to seek treatment with confidentiality, therefore decreasing
stigmatization.14 As substance use was on the rise in the 1960s, law enforcement
attempted to control illegal substance use through punitive measures; however, by
the late 60s and early 70s, they realized this punitive method was ineffective.15
Furthermore, fear of discrimination deterred people from entering substance use
treatment programs.16 To move away from punishment and towards treatment, the
federal government first enacted the Comprehensive Alcohol Use and Alcoholism
Prevention, Treatment and Rehabilitation Act of 1970.17 This Act encouraged people
to view SUD as a medical problem, rather than a moral problem.18 The government
next enacted the Substance Use Office and Treatment Act of 1972, aimed at
supporting treatment and rehabilitation programs.19
Title 42 Part 2 was then enacted in 1975 pursuant to authority given in the
previous Acts.20 A joint action of the Special Action Office for Substance Use
Prevention and the Department of Health, Education, and Welfare (later renamed
The Department of Health and Human Services (HHS)) enacted Part 2 due to a
transfer of authority from the Director of the Special Action Office for Substance
Use Prevention, to the Secretary of the Department of Health, Education, and
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42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records, SUBSTANCE ABUSE &
MENTAL HEALTH SERVS. ADMIN., https://www.samhsa.gov/health-information-technology/lawsregulations-guidelines
[https://web.archive.org/web/20190109052630/https://www.samhsa.gov/health-informationtechnology/laws-regulations-guidelines] (last updated Oct. 12, 2018).
See Part 2—Confidentiality of Alcohol and Drug Abuse Patient Records, 40 Fed. Reg. 27,802.
David F. Musto, Drug Abuse Research in Historical Perspective, in INST. MED., PATHWAYS OF
ADDICTION: OPPORTUNITIES IN DRUG ABUSE RESEARCH app. B, at 284, 290 (1996).
Mitchell Berger, Confidentiality of Substance Use Disorder Patient Records Final Rule (42 CFR
Part 2), RESIDENTIAL SUBSTANCE ABUSE TREATMENT–TRAINING & TECHNICAL ASSISTANCE 1, 3
(2017), http://www.rsat-tta.com/Files/Confidentiality-Rules-and-Regulations_BERGER-(1).
Id.
History of NIAAA, NAT’L INST. ALCOHOL ABUSE & ALCOHOLISM, https://www.niaaa.nih.gov/ourwork/history-niaaa (last visited Oct. 1, 2018).
See Berger, supra note 16; Richard Nixon, Statement About the Substance Use Office and
Treatment Act of 1972, AM. PRESIDENCY PROJECT (Mar. 21, 1972),
https://www.presidency.ucsb.edu/node/255218 (including information about the “balanced attack”
to prosecute the “heroin pusher” in order to protect the “pusher’s victim”).
Drug Abuse Office and Treatment Act of 1972, Pub. L. No. 92-255, 86 Stat. 65 (1972);
Comprehensive Alcohol Use and Alcoholism Prevention, Treatment, and Rehabilitative Act of
1970, Pub. L. No. 91-616, 84 Stat. 1848 (1970) (providing legislative authority to enact the 1975
regulation).
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Welfare.21 Part 2 governs confidentiality in federally-assisted SUD treatment
programs.22 In most circumstances, the regulation requires that providers obtain
patients’ consent before releasing information to others.23 This regulation furthers
the purpose of protecting those with SUD from stigmatization.24
The 1975 version of Part 2 was the first legislation to give minors
confidentiality rights in SUD treatment.25 Its purpose was to allow minors
confidentiality without interfering in parent-child relationships, and to be
consistent with local policy and reinforce the importance that states placed on
family relationships.26 The rule states disclosures may be made if in the patient’s
best interest,27 but it does not explicitly define capacity to give consent to
confidentiality and how to assess it. The regulation was written so treatment
providers would not be torn between violating Part 2 and acting in the minor
patient’s best interests: “[O]ther rule(s) could subject clinicians to an intolerable
choice between violating the provisions of this part . . . , or failing to take action to
avoid a preventable tragedy involving a minor. . . . The statutes . . . should not be
read as requiring such a choice.”28
Part 2 was last substantially updated in 1987 with respect to payment
information and criminal justice system referrals.29 With the widespread
advancement of technology since 1987, the regulation desperately needed updates,
including the integration of information sharing with electronic health records
(EHRs)30 which risk breaching confidentiality and could deter fearful patients from
seeking SUD treatment due to the stigma.31 The former director of the Center for
Substance Use Treatment at Substance Abuse and Mental Health Services
Administration (SAMHSA), Dr. H. Westley Clark, was responsible for interpreting
the previous version of Part 2.32 Clark believed that some EHR sellers who
21
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Confidentiality of Alcohol and Drug Abuse Patient Records, 40 Fed. Reg. 20,522 (proposed May 9,
1975) (to be codified at 42 C.F.R. pt. 2); Part 2—Confidentiality of Alcohol and Drug Abuse
Patient Records, 40 Fed. Reg. 27,802. See also Comprehensive Alcohol Use and Alcoholism
Prevention, Treatment, and Rehabilitative Act of 1970, Pub. L. No. 93-282, 88 Stat. 138.
42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records, supra note 13.
Id.
See id.
See Part 2—Confidentiality of Alcohol and Drug Abuse Patient Records, 40 Fed. Reg. 27,802
(July 1, 1975) (to be codified at 42 C.F.R. pt. 2).
Id.
Id.
Id.
42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records, supra note 13; see also
Confidentiality of Alcohol and Drug Abuse Patient Records, 52 Fed. Reg. 21,796 (June 9, 1987)
(to be codified at 42 C.F.R. pt. 2) (changing “Minor patients.” from Section 2.15 to 2.14 with
minimal changes to the text).
Alison Knopf, Upcoming Rule on 42 CFR Part 2 Could Harm SUD Patients, 29 ALCOHOLISM &
DRUG ABUSE WEEKLY 3, 4 (2017).
Id.
Id.
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previously struggled with Part 2 compliance simply wished to update the regulation
for business interests, particularly because of the opioid epidemic and the nation’s
concern surrounding substance use. 33 Based on this national issues some EHR
system vendors hoped that their products would see increased sales.34 Around 2010,
prior to the current updates, SAMHSA worked to help health providers integrate
technology into their Part 2 compliance efforts.35 Despite these efforts, stakeholders
were still requesting regulatory updates.36
In February of 2016, HHS published new proposed rule changes to Part 2.37
SAMHSA published the final rule, and in February 2017, the rule went into effect.38
The regulation was renamed from “Confidentiality of Alcohol and Substance Use
Patient Records” to ‘‘Confidentiality of Substance Use Disorder Patient Records.’’39
Section 2.14 currently states, “If a minor patient acting alone has the legal capacity
under the applicable state law to apply for and obtain substance use disorder
treatment, any written consent for disclosure . . . may be given only by the minor
patient.”40 The updates to Part 2 should ultimately help treatment providers
incorporate health care delivery systems, including electronic information sharing.41
Changes to Part 2 will ultimately allow SUD treatment information to be
shared with others in the same healthcare system with consent, while leaving in
place existing confidentiality provisions for all communications outside the
healthcare system.42 Compared to different health information privacy laws like the
Health Insurance Portability and Accountability Act (HIPAA), Part 2 contains the
strictest health privacy standards because disclosure of SUD may subject patients
to discrimination or legal consequences.43
The purpose of these updates applies to minors as well. One of the issues
with Section 2.14 is that although there were no changes to this “Minor patients”
section, comments were made with “specific suggestions or requested

33
34
35

36
37
38
39
40
41

42

43

Id.
Id.
Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. 6052 (Jan. 18, 2017) (to
be codified at 42 C.F.R. pt. 2).
Id.
Id.
Id.
Id.
42 C.F.R. § 2.14(a) (2018).
Id. See Confidentiality of Substance Use Disorder Patient Records, 81 Fed. Reg. 6988 (proposed
Feb. 9, 2016) (to be codified at 42 C.F.R. pt. 2).
Setting the Record Straight: ASAM’s Position in 42 CFR Part 2, AM. SOC’Y ADDICTION MED. (Aug.
11, 2017), https://www.asam.org/advocacy/issues/confidentiality-(42-cfr-part-2).
HHS Publishes Final Rule on Confidentiality of Substance Use Disorder Patient Records, HIPAA
J. (Jan. 3, 2018), https://www.hipaajournal.com/final-rule-confidentiality-of-substance-usedisorder-patient-records.
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clarification.”44 Commenters ranged from health insurance management
associations to behavioral health management organizations.45
II.

PSYCHOLOGICAL EFFECTS OF MEDICAL CARE FOR MINORS
A. Minors’ Desire for Confidentiality in Health Care

Many minors prioritize confidentiality and autonomy in their medical
decision making. One study found that one-fourth of participating adolescents
would not seek general health care if they believed that their parents, friends, or
teachers could find out.46 These findings confirmed that a lack of confidentiality
may create a barrier to health care.47 A later study noted that 76% of teens wanted
to obtain health care without parental knowledge,48 and 8% of teens wanted health
care in the previous twelve months, but did not seek it, fearing that their parents
would be notified.49 However, confidentiality may not be enough; 7% of teens who
believed their provider would keep information confidential still did not seek
healthcare out of fear that their parents would find out.50 Therefore, although
minors desire confidentiality and it is an important predictor of whether adolescents
will seek health care, its presence does not guarantee that adolescents will seek
health care.51
B. Current Substance Use Trends Among Minors
SUD affects adolescents of all populations. When compared to Caucasian
adolescents, African-American students reported less substance use, and Hispanic
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Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. 6105 (Jan. 18, 2017) (to
be codified at 42 C.F.R. pt. 2).
Rhode Island Quality Health Institute, Comment Letter on Proposed Rule to Confidentiality of
Substance Use Disorder Patient Records (Apr. 11, 2016),
https://www.regulations.gov/document?D=HHS-OS-2016-0005-0222; Beacon Health Options,
Comment Letter on Proposed Rule to Confidentiality of Substance Use Disorder Patient Records
(Apr. 11, 2016), https://www.regulations.gov/document?D=HHS-OS-2016-0005-0292; Association
for Behavioral Health and Wellness, Comment Letter on Proposed Rule to Confidentiality of
Substance Use Disorder Patient Records (Feb. 17, 2017),
https://www.regulations.gov/document?D=HHS-OS-2016-0005-0402.
Tina L. Cheng, Judith A. Savageau, Ann L. Sattler & Thomas G. DeWitt, Confidentiality in
Health Care: A Survey of Knowledge, Perceptions, and Attitudes Among High School Students,
269 JAMA 1404, 1406 (1993) (study conducted by Cheng et al.).
Id.
Jeannie S. Thrall, Lois McCloskey, Susan L. Ettner, Edward Rothman, Joan E. Tighe & S. Jean
Emans, Confidentiality and Adolescents’ Use of Providers for Health Information and for Pelvic
Examinations, 154 ARCHIVES PEDIATRICS & ADOLESCENT MED. 885, 886 (2000) (study conducted
by Thrall et al.).
Id. at 888.
Id. at 886, 889 (finding 45% believed their regular provider could keep health services
confidential).
Id.
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adolescents reported more substance use.52 Maternal and paternal knowledge of
adolescent substance use led to a lower likelihood that adolescents will use
substances.53 Open communication between parents and adolescents about alcohol
use and its effects was a significant predictor for lower levels of drinking.54
Furthermore, parent permissiveness of substance use, or parental substance use
itself, increased the likelihood that adolescents would engage in substance use.55
Studies confirmed that alcohol and marijuana use were higher in the middle- to
upper-class communities of adolescents, possibly because these adolescents have the
funds to obtain substances and fake identification.56
Reducing risk factors and enhancing protective factors have also been linked
to protecting adolescents from SUD.57 Risk factors include external elements like
permissive parenting, bullying, and living in a community with high drug
tolerance.58 Protective factors look to combat these risks by giving adolescents a
strong bond with parents, spending time around positive role models, and
promoting the belief that substance use can be dangerous.59 Environmental factors
are prevalent throughout research because, when compared to genetic factors,
environmental factors may be more easily addressed.
On the whole, substance use among minors is currently on the decline.60
Adolescents’ use of illicit substances, other than marijuana, has decreased, this
overall includes a decrease in prescription opioid use, and researchers have also
identified a decrease in binge alcohol use.61 However, harmful substances are still a
problem among teens, with alcohol and tobacco as the most frequently used
substances and marijuana a close third.62 Teens are more accepting of marijuana;
52
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Jing Wang, Bruce G. Simons-Morton, Tilda Farhart & Jeremy W. Luk, Socio-Demographic
Variability in Adolescent Substance Use: Mediation by Parents and Peer, PUBMED CENT. 1, 6
(2011) (study conducted by Wang et al.).
Id. at 10.
Does Socioeconomic Advantage Lessen the Risk of Adolescent Substance Use?, HAZELDEN BETTY
FORD FOUND., https://www.hazeldenbettyford.org/education/bcr/addictionresearch/socioeconomic-advantage-edt-818 (last visited Nov. 17, 2018) (findings based on a 2016
study from Hausheer, Doumas, Esp & Cuffee).
Id. (findings based on a 2017 study from Cambron, Kosterman, Catalano, Guttmannova &
Hawkins).
Id. (study conducted by Luthar and Milliren et al.).
Why Do Teens Use Drugs?, GET SMART ABOUT DRUGS (Aug. 14, 2018),
https://www.getsmartaboutdrugs.gov/family/why-do-teens-use-drugs.
Id.
Id.
See Monitoring the Future Survey: High School and Youth Trends, NAT’L INST. ON DRUG USE
(Dec. 2019), https://www.drugabuse.gov/publications/drugfacts/monitoring-future-survey-highschool-youth-trends.
Id. (conducting a study of 8th, 10th, and 12th graders).
What Drugs are Most Frequently Used by Adolescents?, NAT’L INST. ON DRUG USE (Jan. 2014),
https://www.drugabuse.gov/publications/principles-adolescent-substance-use-disorder-treatment-
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only 29% of twelfth graders believe that “regular marijuana use poses a great risk,”
and daily marijuana use among twelfth graders is currently higher than cigarette
use.63 The National Institute for Substance Use for Teens noted that twelfth
graders’ use of marijuana has risen from 5.1% in 2007 to 5.9% in 2017.64
Additionally, adolescents’ opioid use is increasing. According to data from a
2002–2006 Monitoring the Future survey, “1 out of 8 high school seniors reported
having used prescription opioids nonmedically [and] 7 out of 10 nonmedical users
reported combining prescription opioids with at least one other substance in the
past year.”65 According to a study by Dr. Marcel Casavant, 30% of calls to U.S.
poison control centers for children ingesting prescription opioids were for teenagers
who had taken the opioids intentionally to get high or for self-harm.66 Of the 175
children who died from ingesting opioids, 55% were teenagers; however, the rate of
calls per 100,000 adolescents decreased from 80% in 2009 to 50% by 2015.67 The
excessive use of substances by adolescents may create larger repercussions on their
mental states.
C. Effects of Substance Use on Minors
Adolescents’ substance use presents physical and psychological health issues.
A substantial amount of brain growth happens during the adolescent and teen
years. The prefrontal cortex, which makes decisions, continues to develop until the
mid-20s.68 The prefrontal cortex regulates decision-making, reasoning, personality
expression, and social behavior.69 The development in the prefrontal cortex, or
“frontalization,” may underlie adolescents’ growing ability to think about how they
are perceived by others, leading to increased feelings that they are constantly being
judged.70 According to Harvard University’s Isabelle Rosso, PhD, as abstract

63
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research-based-guide/frequently-asked-questions/what-drugs-are-most-frequently-used-byadolescents.
Id. See Teens Mix Prescription Opioids with Other Substances, NAT’L INST. ON SUBSTANCE USE
(Apr. 2013), https://www.drugabuse.gov/related-topics/trends-statistics/infographics/teens-mixprescription-opioids-other-substances (finding most common combination of substances among
youths in a 2002–2006 study was marijuana and alcohol (58.5% and 52.1%)).
Shamard Charles, Marijuana Worse for Teen Brains than Alcohol, Study Finds, NBC NEWS (Oct.
3, 2018), https://www.nbcnews.com/health/kids-health/marijuana-may-be-worse-teen-brainsalcohol-study-finds-n916296.
Teens Mix Prescription Opioids with Other Substances, supra note 63.
Amy Norton, Fewer U.S. Kids Overdosing on Opioids, WEBMD (Mar. 20, 2017),
https://www.webmd.com/mental-health/addiction/news/20170320/fewer-us-kids-overdosing-onopioids.
Id. (“This study can’t show why.”).
How Drugs Alter Brain Development and Affect Teens, GET SMART ABOUT DRUGS (Feb. 7, 2020),
https://www.getsmartaboutdrugs.gov/consequences/how-drugs-alter-brain-development-andaffect-teens.
Erika Packard, That Teenage Feeling, 38 AM. PSYCHOL. ASS’N 20, 21 (Apr. 2007),
https://www.apa.org/monitor/apr07/teenage.aspx.
Id.
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reasoning increases, including the ability to make inferences about others’ thoughts
and feelings, so does social anxiety, which may make adolescents feel more
vulnerable and self-conscious.71 SUD may affect this brain development and
psychological growth.
During brain maturation, the frontal lobe, associated with “planning,
inhibition, emotional regulation, and integration of novel stimuli,” increases in
efficiency.72 The brain’s plasticity permits large learning capacity, which may be
affected by alcohol and substance use.73 Exposure to harmful substances during a
period of key brain development “interrupt[s] the natural course of brain
maturation.”74 Substance use in pre-teenagers has extraordinary risks because it
increases the likelihood that this use will progress to more dangerous substances, in
turn affecting the adolescent’s “physical, physiologic, neurologic, and emotional
development.”75
Heavy drinking in teen years disturbs the working memory, including
“attention, information retrieval, . . . visuospatial functioning,” information
processing speed, and executive functioning.76 In a study by Brown et al., adolescent
drinkers recalled 10% less verbal and nonverbal information compared to nondrinkers.77 Even after the minor stops drinking, it may be weeks or months until
the brain is back to its optimal capacity.78
Marijuana use causes similar neurological damage among adolescents. Many
believe that marijuana is less harmful than alcohol; however, many recent studies
confirm that it may be more harmful.79 Adolescents who use marijuana have “a less
efficient pattern of activation compared to non-users on working memory, verbal
learning, and cognitive control tasks.”80 Further, Cass et al. found that early
71
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Id. Isabelle Rosso, PhD, works in Harvard University's McLean Hospital Cognitive
Neuroimaging and Neuropsychology Laboratory. Id.
L.M. Squeglia, J. Jacobus & S.F. Tapert, The Influence of Substance Use on Adolescent Brain
Development, 40 CLINICAL EEG & NEUROSCIENCE 31, 32 (2010) (“In a study comparing prefrontal
cortex volumes of adolescent heavy drinkers to non-drinkers and marijuana and alcohol users,
prefrontal volumes were smaller in heavy drinkers relative to controls.”).
Richard C. Bodlt, Symposium, Adolescent Decision Making: Legal Issues with Respect to
Treatment for Substance Misuse and Mental Illness, 15 J. HEALTH CARE L. & POL’Y 75, 87 (2012).
Squeglia et al., supra note 72, at 2.
John W. Kulig & The Comm. on Substance Abuse, Tobacco, Alcohol, and Other Drugs: The Role
of the Pediatrician in Prevention and Management of Substance Abuse, 115 J. AM. ACAD.
PEDIATRICS 816, 820 (2005).
Sunita Bava & Susan F. Tapert, Adolescent Brain Development and the Risk for Alcohol and
Other Drug Problems, 20 NEUROPSYCHOLOGY REV. 398, 405 (2010).
Squeglia et al., supra note 72, at 32 (continuing verbal and nonverbal problems even three weeks
after abstinence).
How Drugs Alter Brain Development and Affect Teens, supra note 67.
Charles, supra note 64 (according to a study published in the American Journal of Psychiatry,
marijuana has a more damaging long-term effect on the cognitive abilities of teenagers than
alcohol).
Bava & Tapert, supra note 76.
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adolescent brain receptors repeatedly exposed to cannabinoids ultimately
experienced a slowed prefrontal cortex.81 These deficiencies linger, and after four
weeks of abstinence, adolescents who regularly smoked continued to poorly perform
on tests of working memory, learning, and cognitive flexibility, along with other
performance tests.82 These same adolescents with SUD have shown their capacity to
make good decisions by seeking treatment, but other decisions might be challenging
in different ways because of the adolescent’s immaturity compounded by the
cognitive deficits of substance use.83 The new decision-making hurdles that
adolescents might face also surround social and relational fears, showing the need
to destigmatize SUD.84 Providers must fully evaluate both the nature and extent of
the substance use in order to offer counseling that is appropriate, or know when to
make referrals.85
D. Treatment Alternatives for SUD
There are numerous types of treatments that may be used for adolescents
with SUD, and not all treatment options will benefit each adolescent in the same
way.86 There are behavioral approaches that work to “modify [adolescents’]
attitudes and behaviors related to drug abuse” and assist with other communication
issues or environmental reasons an adolescent would use substances.87 Group
therapy also allows adolescents to connect with and receive support from their
peers.88 Family-based treatments may be more effective than individual and group
treatment approaches, allowing parents and family into the process of the SUD
recovery to both communicate and work on conflict resolution.89
SAMHSA notes the importance of social support and building meaningful
relationships within the community in SUD recovery.90 Social support may vary
among adolescents who may have different primary relationships in their lives;
some may confide in peers, while others may involve parents or a trusted adult.91
Upon entering SUD treatment, providers must know the adolescent’s relational
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Study: Regularly Using Marijuana as a Teen Slows Brain Development, GET SMART ABOUT
DRUGS (Oct. 13, 2017), https://www.getsmartaboutsubstances.gov/newsstatistics/2017/04/14/study-regularly-using-marijuana-teen-slows-brain-development.
Squeglia et al., supra note 72, at 3.
See supra Part II.C.
See Packard, supra note 69.
Id.
NAT’L INST. ON DRUG ABUSE, PRINCIPLES OF ADOLESCENT SUBSTANCE USE DISORDER TREATMENT
23 (2014).
Id.
Id.
See id. at 17.
Recovery and Recovery Support, SUBSTANCE ABUSE AND MENTAL HEALTH ADMIN. (Oct. 2018),
https://www.samhsa.gov/recovery.
See id.
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network and their strengths and weaknesses.92 Providers must understand the
culture of the community that they serve, including the community’s values and
traditions, in order to create and advise effective treatment plans.93
Adolescents undergoing SUD treatment must be fully informed of the various
types of treatment. Further, adolescents should be informed of the treatment
options that may no longer be available to them if they chose to make their SUD
treatment confidential.
III. STANDARDS FOR CAPACITY AND UNDERSTANDING WITHIN MEDICAL DECISIONS
Adolescents dealing with SUD have the capacity to seek treatment.94 There is
not an issue with allowing minors to access treatment; however, the problem with
current treatment regulations stems from the fact that most of these adolescents
may have trouble making decisions about treatment options because they may
overestimate how SUD stigma can harm their relationships and underestimate the
importance of support networks.95 Immaturity and increased vulnerability make
these issues more complex.96 Adolescents have an appraisal system tasked with
weighing the positives and negatives of decisions.97 The appraisal system “overemphasizes the positive aspects of a choice, and de-emphasizes the negative aspects
of a choice.”98 Adolescents who are more likely to have an SUD have a hyperrational brain,99 meaning the adolescents place more weight on the benefit than the
risk.100 Therefore, adolescents who have a heightened hyper-rational brain may not
be able to appropriately weigh the “risk” of telling their parent against the
benefit.101 Moreover, the substance use, depending on nature and type, may have
further damaged the adolescent’s ability to fully consider the decision of
confidentiality.
Adolescents have made the good decision to seek treatment; however, based
on the nature of SUD, further assistance may be necessary to achieve broader
understanding of the role of support and the need to disclose their SUD. These
adolescents must be provided adequate information, based on their maturity, in
order for them to receive the best treatment possible.
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See id.
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See 42 C.F.R. § 2.14(a) (2018).
See supra notes 86, 90.
Supra Part II.C.
Michael Dahr, Is the Teen Brain More Vulnerable to Addiction?, HUFFPOST (Jan. 21, 2014),
https://www.huffpost.com/entry/teen-brain-addiction-vulnerable_n_4638723.
Id.
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Todd Finley, Your Face Scares Me: Understanding the Hyperrational Adolescent Brain,
EDUTOPIA (June 10, 2014), https://www.edutopia.org/blog/understanding-the-hyperrationaladolescent-brain-todd-finley.
See id.
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A. Medical Informed Consent
Along with capacity, informed consent is important within the medical
decision-making process. There are four elements that must be met for informed
consent: (1) the person must have the capacity to make the decision; (2) the provider
must disclose all information, including the likelihood of benefits and risks; (3) the
information must be understood; and (4) the patient must voluntarily consent.102
Providers must tell patients the material information a reasonable person would
need to make an intelligent decision.103 Disclosure includes the likelihood of the
risks and the benefits, side effects, and alternatives to whatever procedure or
treatment option is discussed.104 Informed consent is vital to patient autonomy,
allowing patients to make their own medical decisions.105 Further, informed consent
must be obtained before patients’ medical information can be released.
B. Medical Capacity and Providers’ Ethical Duties
When caring for patients, physicians rely on four elements to assess
capacity.106 Patients must have: (1) understanding of relevant information about
proposed diagnostic treatment; (2) appreciation for their situation; (3) reasoning
used to make decisions; and (4) the ability to communicate their choice.107 Medical
scholars have noted that, where patients’ capacity is in question, other experts like
psychiatrists should be used.108
The American Medical Association (AMA) Code of Medical Ethics provides
further guidance on challenging ethical questions that many providers face when
dealing with their patients, the law, and their morals.109 The Opinion, “Confidential
Care for Minors,”110 states that minors should be involved in the medical decision
process to the extent that their abilities allow.111 Providers are encouraged to give
minors as much autonomy as possible so minors feel in control of their treatment;
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Richard A. Wagner, Informed Consent, EMEDICINE HEALTH (Oct. 17, 2018),
https://www.emedicinehealth.com/informed_consent/article_em.htm#what_is_informed_consent.
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Assessing Medical Decision-Making Capacity, PHYSICIANS WEEKLY (May 8, 2012),
https://www.physiciansweekly.com/medical-decision-making-capacity/.
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Joyeeta G. Dastidar & Andy Odden, How Do I Determine if My Patient Has Decision-Making
Capacity?, THE HOSPITALIST (Aug. 2011), https://www.the-hospitalist.org/hospitalist/article/
124731/how-do-i-determine-if-my-patient-has-decision-making-capacity.
See AMA CODE OF MEDICAL ETHICS, https://www.ama-assn.org/delivering-care/ama-codemedical-ethics (last updated 2018).
Opinion 5.055-Confidential Care for Minors, AM. MED. ASS’N J. ETHICS (Nov. 2014),
https://journalofethics.ama-assn.org/article/ama-code-medical-ethics-opinion-adolescentcare/2014-11.
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however, physicians should also encourage parental involvement.112 The Opinion
notes that, especially regarding substance and alcohol use, “when the physician
believes that, without parental involvement and guidance, the minor will face a
serious health threat, and there is reason to believe that the parents will be helpful
and understanding, disclosing the problem to the parents is ethically justified.”113
Before disclosure, the breach of confidentiality must be discussed with the minor
patient, and at times, the AMA supports following the child’s disclosure wishes.114
C. Legal Capacity
Legal capacity comes into question in many decision-making circumstances.
To determine capacity, courts look at one’s ability to reason, deliberate, hold both
values and goals, appreciate circumstances, understand information, and
communicate a choice.115 Capacity may change over time; therefore, repeated
assessments of capacity may be necessary.116 One perspective courts use is that
capacity is a balancing act examining how much autonomy a person possesses and
how much value lies in respecting the autonomy.117 Generally, the higher a person’s
level of capacity, the more that person’s autonomy will be respected.118 Adolescents’
ability to deliberate or reason may be diminished by immaturity, poor
understanding of actions and consequences, and SUD’s effect on the brain.119 For
example, adolescents may overestimate the threat of telling parents about their
SUD.
D. Traditional Legal Treatment of Minors in Health Decisions
The legal system has traditionally viewed children and teens as a vulnerable
group, subject to extra protections.120 The Supreme Court has articulated that “[o]ur
history is replete with laws and judicial recognition that minors . . . generally are
less mature and responsible than adults. Particularly ‘during the formative years of
childhood and adolescence, minors often lack the experience, perspective, and
judgment’ expected of adults.”121 The legal system assumes that adults are
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Alec Buchanan, Mental Capacity, Legal Competence and Consent to Treatment, 97 J. ROYAL
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See supra Part II.C.
See What are the Legal Rights of Children?, FINDLAW.COM,
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Thompson v. Oklahoma, 487 U.S. 815, 834 (1988) (quoting Bellotti v. Baird, 443 U.S. 622, 635
(1979)).
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competent, but children often must prove that they are competent.122 While
research shows that some children demonstrate adult competence around the age of
fourteen, this depends on the situation and the complexity of the issues that the
minor faces.123 Thus, minors who make decisions often deserve protection according
to the law.
Courts have historically distinguished children and adults124 because
children are psychologically more vulnerable to external influences.125 In Bellotti v.
Baird, the Supreme Court ultimately decided that, although minors did not need
parental approval for abortions, their autonomy and ability to seek treatment
cannot be the same as adults because of vulnerability, their inability to make
mature, informed decisions, and the importance of parents’ role in raising their
children.126 The Supreme Court found that, while the child did not need parental
approval before obtaining an abortion, children still represent a protected class due
in part to their vulnerability.127 Bellotti v. Baird gives children extra protections
even if parents are not involved in the initial medical decision-making process.128
Based on precedent, extra protections should be afforded to adolescents seeking
SUD treatment. The protections should manifest in the way that adolescents are
being informed of their treatment options because not only do adolescents generally
lack maturity, but, in these cases, they also suffer from the deficit of the SUD.
The Supreme Court again noted the seriousness of children’s medical
decisions prompting stigma. In Parham v. J.R., concerning a child’s involuntary
institutionalization because of mental illness, the Court noted the importance of
determining whether institutionalization was necessary because it was
stigmatizing;129 therefore, it was decided that other professionals should confirm
treatment needs besides simply relying on the decision of the parents.130 Courts will
insert themselves into familial relationships to protect children’s interests only in
the most serious cases,131 because “parents can and usually do play a significant
role in the treatment . . . [and] there is a serious risk that an adversary
confrontation will adversely affect the ability of the parents to assist the child.”132
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Richard E. Redding, Children’s Competence to Provide Informed Consent for Mental Health
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Id. at 725, 727.
Thompson v. Oklahoma, 487 U.S. at 823 (prohibiting the execution of a person who was sixteen
years old at the time of the committed murder).
Id. at 834 (quoting Eddings v. Oklahoma, 455 U.S. 104, 115–16 (1982)).
443 U.S. 622, 633–34 (1979) (finding mature minors can go to the court to receive court consent
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While courts will interfere with children’s medical decisions made by parents,
courts interference will clearly be in very limited and stigmatizing circumstances.
Not all advocates agree with the precedent of protecting minors and
questioning their decision-making abilities, but instead see children’s legal and
societal lack of decision-making ability as an affront to their dignity.133 Some
believe that children are “the most oppressed of all the minorities” because they are
unable to make their own life decisions.134 Children’s rights advocates note that in
order for children to not be mistreated, they should always receive a say in the
decisions affecting their lives.135 Many feel that as children possess a voice
regarding their life decisions they are then provided with a higher level of
autonomy.136
However, similar to the Supreme Court noting that parents may “play a
significant role in treatment,” parental involvement should be encouraged in most
forms of SUD treatment.137 The confidentiality in Section 2.14 for minors may place
a chilling effect on both providers encouraging parental involvement in treatment,
and adolescents fully understanding the benefits which they are closing themselves
off from with confidentiality.
IV. ISSUES OF CONFIDENTIALITY AND MINOR PATIENTS WITHIN SECTION 2.14(C)
There are times when providers may breach confidentiality because
significant harm may arise from not reporting SUD treatment.138 It is important to
note that adolescents have the capacity to enter into the initial SUD treatment,
therefore initial capacity should not be considered.139 Based on Section 2.14(c), there
are a few situations where treatment providers can break confidentiality.140 Section
(c) of “Minor patients” articulates that confidentiality for the minor can be broken if
the minor:
lacks capacity for rational choice. Facts relevant to reducing a
substantial threat to the life or physical well-being of the minor
applicant . . . may be disclosed to the parent . . . or other individual
authorized under state law to act in the minor's behalf if the part 2
program director judges that: (1) A minor applicant for services lacks
capacity because of extreme youth[ ](sic.) or mental or physical
condition to make a rational decision on whether to consent to a
disclosure . . . to their parent . . . or other individual authorized under
133
134
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See Redding, supra note 122, at 704.
Id. (quoting THE CHILDREN’S RIGHTS MOVEMENT: OVERCOMING THE OPPRESSION OF YOUNG
PEOPLE 1 (Beatrice Gross & Ronald Gross eds., 1977)).
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state law to act in the minor's behalf; and (2) The minor applicant's
situation poses a substantial threat to the life or physical well-being of
the minor applicant . . . which may be reduced by communicating
relevant facts to the minor's parent . . . or other individual authorized
under state law to act in the minor's behalf.141
Similar to the public’s comments about the vagueness of the regulation,142 more
guidance should be given to treatment providers on how to assess the adolescent’s
maturity or ability to make a “rational choice.” Treatment providers should also be
given better guidelines to understand the “substantial threat[s]” that can be caused
by SUD. Analysis of section (c) is necessary to understand where additions and
clarifications are needed within the regulation.
A. Minors Lacking Maturity Based on Psychological Studies and Supreme Court
Precedent within Section 2.14(c)(1)
Most adolescents have the initial level of capacity to receive SUD treatment;
however, the mental state of adolescents should be taken into consideration and
continually reassessed, especially for confidentiality within substance use
treatments.143 Considering subsection (1) of Section 2.14(c), regarding mental
conditions affecting an adolescent’s ability to make a “rational decision,” treatment
providers should be considering what type of substance the youth has been using
and how long use has occurred.144 This would include issues like heavy drinking,
which is known to cause problems with the working memory,145 and regular
marijuana use, which causes problems with decision-making ability.146
When examining the substantially precarious mental state of children with
SUD, it is important to consider that they have a decision-making deficit that stems
from the implications of substance use on the growing brain, along with
immaturity.147 While the core issue is not a “mental . . . condition,”148 there is
instead a lack of understanding and appreciation that continued confidentiality may
be problematic for their treatment. While inclusion of adolescents in decisionmaking proves important for development and trust,149 there may be times, based
on psychological states, that they lack the maturity to fully make decisions.
Further, involving adolescents in the decision-making process does not negate the
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Supra notes 44–45 and accompanying text.
See Buchanan, supra note 115, at 415.
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See supra Part II.C.
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fact that most parents should, at most times, be aware of what happens in their
children’s lives, especially with SUD treatment decisions.150
B. Substantial Threat to the Well-being of Minors Under Section 2.14(c)(2)
Confidentiality of minors within a substance use treatment program may also
be broken if “[t]he minor applicant's situation poses a substantial threat to the life
or physical well-being of the minor applicant . . . which may be reduced by
communicating relevant facts to the minor's parent.”151 The substantial threat
would most likely come from the type and amount of the substances the adolescent
uses.152 Adolescents using opioids should most likely be reported to parents or
guardians due to the serious and substantive information that has been gathered
surrounding the opioid epidemic and its serious effects on adolescents; for example,
55% of child opioid deaths in a poison control study were teenagers.153 Parents
should also be notified when certain lethal combinations of substances are used.
Not only should treatment providers look at the type and frequency of
substance use, but the providers must also balance the seriousness of the
adolescent’s issues with the risks or benefits of parental involvement. Family-based
treatments can be more effective than individual and group treatment
approaches.154 Including parents and family in SUD treatment allows children to
improve communication skills and work on conflict resolution within the family,155
helping to identify and manage any underlying problems related to the substance
use and may also allow parents to be supportive.156 Parents can schedule
appointments and “provid[e] needed structure and supervision through household
rules and monitoring.”157 Family involvement should be part of the SUD treatment
package. Treatment providers have a duty to inform minors of the benefits of family
inclusion under the “best interests of the patient” because this is an established
treatment option.158
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Id. at 110.
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While family-based treatments have been found to be beneficial to
adolescents, in some cases, involving parents in SUD treatment could jeopardize
success. Adolescents could be further harmed if their SUD comes from a
dysfunctional family relationship or from inappropriate or harmful relationships
with parents.159 However, the National Institute on Drug Abuse noted that some
therapy combinations of family-based treatment and individual treatment can be
very beneficial for adolescents because they allow children to confront parents and
identify issues in a healthy setting.160 These treatments work to improve
“communication, problem-solving, conflict resolution, and parenting skills.”161
Further, studies have found that simply having social support aids in the treatment
process.162 The information on the substantial benefits of the family-based
treatment, depending on the nature of the problem of the adolescent’s substance
use, may outweigh the benefits of confidentiality.
V.

PROPOSED SOLUTION TO THE VAGUENESS OF 42 CFR 2.14(C)

Section 2.14 of the regulation should be further updated to include more
specific guidelines for minors and confidentiality.163 Adolescents have the capacity
to seek treatment, but once they do, they then need the social support to make good
decisions in the future.164 Removal of confidentiality may benefit future decision
making. Updates should focus on adolescents making a “rational decision” by
receiving full information from providers about the benefits of family-based
treatment. Within Section 2.14 there should be full disclosure by providers about
the benefits and risks of social support and family-based treatment. Also, there
should be a clearer exception with Section 2.14(c), allowing confidentiality to be
broken if assessments determine that the adolescent would benefit. The updates
should also focus on providing guidelines so providers can accurately assess, within
Section 2.14(c), if there is “substantial threat or harm” to the adolescent.
Under this updated system, initial confidentiality should apply until
assessment is complete because there are risks that minors will not seek the
treatment both that they need and are willing to receive if confidentiality cannot be
guaranteed.165 While some minors will not seek SUD treatment based on the
possibility that it will be disclosed to their parents or guardians, the initial
confidentiality between the treatment providers and adolescents will build trust
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with those adolescents who do seek help.166 The trust will allow minors to have
more open and honest conversations with their treatment providers, and hopefully
encourage them to accept treatment providers’ advice.167 Similar to the AMA Code
of Medical Ethics guidance for minors’ confidentiality, patients’ opinions must be
considered to promote autonomy; however, if a provider feels that the minor’s
parents should be informed, the provider must discuss this with the minor prior to
disclosure, even if Section 2.14 exceptions are met.168 Conversations built from a
trusting relationship can open channels of communication between the provider and
minor, which ultimately will promote the minor’s wellbeing.169
The updated regulation will allow for more structure as to when providers
can disclose SUD treatment. This proposed plan accords with the purposes
underlying Section 2.14: not interfering with the parent-child relationship and
giving providers freedom to protect minors from possibly harmful situations.170
A. Providing Adolescents Information Necessary for Informed Consent: The
Possible Benefits and Risks of Family-Based Treatment
In order to truly give informed consent, minors must be provided information
about all of the risks and benefits of family-based treatment, and they must fully
understand how confidentiality ties into the obstruction of these possible benefits.
While there is not an extensive body of research, studies have found that familybased treatment is more effective than other treatments that do not use familybased approaches.171 The information about the benefits of family-based treatment
should be explained to adolescents, and providers should make sure to confirm that
the adolescents fully understand this information. Providers should also give
information about the importance of social support benefits, encouraging
adolescents to allow information to be shared with a trusted adult if their parents
are unavailable or would not be helpful. If providers are able, they should also try to
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have a conversation with parents to better determine the parents’ involvement in
the adolescent’s life and their understanding of the child’s substance use.172
The updated regulation would then continue with the inclusion of a mental
health professional. If a minor still refused family-based treatment, a
psychologist173 would need to see the minor to determine if the minor would benefit
from family-based treatment. The psychologist would then be required to document
that family-based treatment would not be helpful in order to completely solidify the
confidentiality. The family-based treatment may not be beneficial if the minor
struggles from a precarious home-life and informing the parents would only
exacerbate the situation.174 However, psychologists will note times when familybased treatment can help adolescents with problems at home, because the
treatment will address those underlying problems.175
Further, the approach would comport with the AMA Code of Medical Ethics,
where if a provider believes that “parents will be helpful and understanding,” the
information about the substance use treatment should be disclosed.176 This
guidance will ensure that minors are being given more information about the
benefits of parental involvement in their SUD treatment. The approach will
emphasize that for true informed consent to exist, minors must understand the
possible benefits that they are giving up in choosing confidentiality.
B. Accessing the Risk for Substantial Harm: The Psychological Effects of the
Amount and the Type of Substance Use
In entering SUD treatment, minors recognize that the substance use is a
problem in their lives, but treatment providers still must identify the problem’s
extent. In the updated framework of the regulation, treatment providers should
identify the length and frequency of the minor’s substance use. Based on studies
illustrating the detriments to an adolescent’s brain due to substance use, the
treatment provider would have to assess whether the SUD limits the minor’s
decision-making ability or affects the adolescent’s brain after the minor’s initial
decision to receive treatment. 177 The assessment would occur not only through
tests, SUD treatment providers also would be presented with a detailed guideline
that defines what drugs should be flagged for possibly categorizing a child as high
risk. The determination of a high risk child would be defined from the regulation as
a child whose SUD combination or use possesses a “substantial threat to the life or
physical well-being of the minor applicant.”178 These guidelines would give SUD
172
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providers more clarity on what high risk looks like or those substances that can
substantially affect the brain, leading to swift and serious outcomes.
Providers would next identify whether the minor has the level of maturity to
properly understand confidentiality. This would also be based on the information
that was previously disclosed about the importance of social support systems and
family-based treatment. The minor would need to show the ability to understand
and appreciate the situation.179 In these cases, the minor would need to be informed
of the risks and benefits of the treatment without including the parents.180 Minors
would demonstrate their maturity not only through the meeting with the provider
but also through several different types of assessments. The assessments would be
administered through counseling to make sure that they understand the benefits of
social support and family-treatment. The assessment would further test their level
of maturity and understanding of the idea of confidentiality and the positives, along
with negatives, of not including parents in treatment. The meetings with the
provider, paired with the examinations, would ensure that minors fully understand
the constraints of confidentiality in relation to their treatment.
These additions to the regulation would protect adolescents who are at high
risk from falling through the cracks of the system or the regulation. Furthermore, it
would ensure that adolescents are fully informed that the benefits of social support
and parental involvement generally outweigh the “risks” of informing parents.
CONCLUSION
Adolescents have been treated as a vulnerable population, subject to extra
protections, within society and the law. Adolescents with SUD may be in a
heightened state of vulnerability because of their lack of maturity, compounded
with the neurological deficits caused by SUD. Research has found that
environmental factors play a large role in the treatment and recovery of adolescents
suffering from SUD.181 These treatment options can range from group therapies to
family-based treatments.182 The benefits of treatment may then come into conflict
with Section 2.14, which has the main purpose of allowing minors to consent to
confidentiality within SUD treatment.
When enacted in 1975, Part 2 served the goal of allowing people, including
minors, to confidentially receive treatment for SUD without the stigma.183 Based on
the current knowledge of the effects of SUD on adolescents’ brains and the
importance of social support, including family-based treatment, Section 2.14 should
be updated to provide clear treatment reasons as to when disclosure of SUD
treatment is necessary. The updates should include full disclosure to adolescents of
179
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the benefits of family-based treatment, ensuring that adolescents fully understand
and consider these benefits, and distinct guidelines for treatment providers to
report SUD treatment to parents based on possible harm.
Ultimately, while the implications of the social stigma should be considered
when treating adolescents with SUD, the social support may not only benefit
adolescents, but may be necessary throughout minors’ treatments. The purpose of
Section 2.14 is to allow minors to seek the treatment that they need; therefore, it is
vital that the regulation does not produce a chilling effect on the treatment, making
providers hesitant to advocate against confidentiality and for family-based
treatment. While the confidentiality and autonomy provided by Section 2.14 prove
important, adolescents still maturing and dealing with the effects of SUD must be
fully informed about how the benefits of family-based treatment may outweigh any
risks that may concern them. In conclusion, the full disclosure of the benefits of
SUD family-based treatments will allow adolescents to give informed consent,
promoting autonomy, while still working to protect and treat these vulnerable
adolescents.

